Sanofi Aventis competitive analysis

Loading summary...

Explore patent oppositions filed by Sanofi Aventis against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 30, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Dosage Measurement Module On Injection PenELI LILLYMar 7, 2025
Methods And Apparatus For Aspects Of A Dose Detection SystemELI LILLYNov 4, 2024
Needle Shield Remover And A Medicament Delivery Device Comprising The Needle Shield RemoverSHL MEDICALAug 22, 2024
Needle Cover AssemblySHL GROUPJan 12, 2024
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)AMGENNov 10, 2023
A Medicament Delivery Device With A Removable Cap And Locking Member For Preventing Accidental ActiviationCONSORT MEDICALAug 16, 2023
Injector Comprising A Destructible Electric Circuit As A Result Of UseTECPHARMA LICENSINGFeb 16, 2023
Rotary Sensor Assembly With Space Efficient DesignNOVO NORDISKDec 22, 2020
Data Acquisiton Means, Especially For A Pen-Type Drug Delivery DevicesBEREYOct 22, 2020
Administration Device Having A Button With Touch SensorF HOFFMANN LA ROCHEJul 30, 2020

Explore Sanofi Aventis's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 30, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 3, 2025Lixisenatide Synthesis With Capping2
May 28, 2025Data Collection Device For Attachment To An Injection Device2
Apr 30, 2025Auto-Injector2
Dec 11, 2024A Device For Attachment To An Injection Device1
Oct 9, 2024Autoinjector1
Nov 29, 2023Syringe Carrier1
Jun 7, 2023Data Collection Apparatus For Attachment To An Injection Device1
Jan 11, 2023Syringe Carrier2
Jun 9, 2021Medical Device And Method For Providing Information For Glycemic Control1
Apr 28, 2021Automatic Injection Device With Torsional Spring1

Latest PTAB cases involving Sanofi Aventis

Discover the latest PTAB cases involving Sanofi Aventis, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 3, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Sanofi Aventis

IPR2019-01658Oct 7, 2019MYLAN PHARMACEUTICALSSANOFI AVENTIS DEUTSCHLANDInstitution Denied
IPR2019-00977May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00978May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00979May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDFinal Written Decision
IPR2019-00980May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00981May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00982May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00987May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-01022May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-01023May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other

Peer Comparison New

IP litigation analysis comparing Sanofi Aventis with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 30, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SANOFI AVENTIS DEUTSCHLAND1630 - 24
MYLAN PHARMACEUTICALS - - 94 -
PFIZER51874312
YPSOMED1814 - -